Int Immunopharmacol. 2012 Jul;13(3):242-4. doi: 10.1016/j.intimp.2012.04.015. Epub 2012 May 3.
PMID:22561120
Immune thrombocytopenia purpura associated with multiple myeloma.
Faller E, Chapman L, Enright H, Browne P, McHugh J, Desmond R.
Ann Hematol. 2016 Aug;95(8):1371-2. doi: 10.1007/s00277-016-2694-y. Epub 2016 May 13.
PMID:27178045
Multiple myeloma developing during long-term clinical course of refractory immune thrombocytopenic purpura: a case report and review of literature.
Yao H, Zhang X, Liu J, Zhu L, Chen G, Wu S, Gao L.
Int J Clin Exp Pathol. 2015 Nov 1;8(11):15429-32. eCollection 2015.
PMID:26823908
Multiple myeloma presenting with a fever of unknown origin and development of thrombotic thrombocytopenic purpura post-bortezomib.
Moore H, Romeril K.
Intern Med J. 2011 Apr;41(4):348-50. doi: 10.1111/j.1445-5994.2011.02458.x.
PMID:21507163
Coexisting Thalassemia, Immune Thrombocytopenic Purpura, and Multiple Myeloma With Osteopenia: Complex Hematologic Case in an Adult Asian Male Patient.
Chambi-Torres JB, Angly S, Michel G.
Cureus. 2024 Dec 8;16(12):e75338. doi: 10.7759/cureus.75338. eCollection 2024 Dec.
PMID:39776720
Daratumumab as a novel treatment option in refractory ITP.